nach oben

Current Addiction Reports

Erschienen in:

01.09.2014 | Addictive Disorders in DSM-5 (JE Grant, Section Editor)

Caffeine Use Disorder: A Review of the Evidence and Future Implications

verfasst von: Merideth A. Addicott

Erschienen in: Current Addiction Reports | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

The latest edition of the Diagnostic and Statistical Manual of Mental Disorders (5th edition; DSM-5) has introduced new provisions for caffeine-related disorders. Caffeine withdrawal is now an officially recognized diagnosis, and criteria for caffeine use disorder have been proposed for additional study. Caffeine use disorder is intended to be characterized by cognitive, behavioral, and physiological symptoms indicative of caffeine use despite significant caffeine-related problems, similar to other substance use disorders. However, since non-problematic caffeine use is so common and widespread, it may be difficult for some health professionals to accept that caffeine use can result in the same types of pathological behaviors caused by alcohol, cocaine, opiates, or other drugs of abuse. Yet there is evidence that some individuals are psychologically and physiologically dependent on caffeine, although the prevalence and severity of these problems is unknown. This article reviews the recent changes to the DSM, the concerns regarding these changes, and some potential impacts these changes could have on caffeine consumers.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Fifth Edition, DSM-5. Arlington: American Psychiatric Association. 2013.

Morelli M, Simola N. Methylxanthines and drug dependence: a focus on interactions with substances of abuse. In: Fredholm BB, editor. Handbook of experimental pharmacology. Berlin Heidelberg: Springer-Verlag; 2011. p. 483–507.

Nehlig A. Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev. 1999;23:563–76.PubMedCrossRef

Satel S. Is caffeine addictive? A review of the literature. Am J Drug Alcohol Abuse. 2006;32:493–502.PubMedCrossRef

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Fourth Edition, DSM-IV. Washington, D.C.: American Psychiatric Association. 1994.

Griffiths RR, Woodson PP. Caffeine physical-dependence - a review of human and laboratory-animal studies. Psychopharmacology. 1988;94:437–51.PubMedCrossRef

Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology. 2004;176:1–29.PubMedCrossRef

Strain EC, Mumford GK, Silverman K, Griffiths RR. Caffeine dependence syndrome - evidence from case-histories and experimental evaluations. JAMA. 1994;272:1043–8.PubMedCrossRef

Juliano LM, Evatt DP, Richards BD, Griffiths RR. Characterization of individuals seeking treatment for caffeine dependence. Psychol Addict Behav. 2012;26:948–54.PubMedCentralPubMedCrossRef

10.

Striley CW, Griffiths RR, Cottler LB. Evaluating dependence criteria for caffeine. J Caffeine Res. 2011;1:219–25.PubMedCentralPubMedCrossRef

11.

Hughes JR, Oliveto AH, Liguori A, Carpenter J, Howard T. Endorsement of DSM-IV dependence criteria among caffeine users. Drug Alcohol Depend. 1998;52:99–107.PubMedCrossRef

12.

Association AP. Substance-related and addictive disorders. DSM-5 Development Fact Sheets 2013. http://www.dsm5.org/Documents/Substance%20Use%20Disorder%20Fact%20Sheet.pdf. Accessed 2 April 2014.

13.••

Striley CW, Hughes JR, Griffiths RR, Juliano LM, Budney AJ. A critical examination of the caffeine provisions in the Diagnostic and Statistical Manual, 5th Edition (DSM-5). J Caffeine Res. 2013;3:101–7. Striley moderated a roundtable discussion examining the caffeine provisions in the DSM-5. Participants were Drs. Hughes, Griffiths, Juliano, and Budney. The discussants provide an overview of the recent changes to the DSM and address the issues and concerns raised by the psychiatric community regarding those changes. Some of these concerns were that a diagnosis of caffeine withdrawal or CUD could trivialize other drug use disorders, and that disordered caffeine use could be over-diagnosed since caffeine is so widely used. The discussants emphasize that more conservative criteria are used to define caffeine withdrawal and CUD than other substance use diagnoses—to help prevent over-diagnosis—and the DSM substance use disorder diagnoses are intended for individuals who experience significant functional impairment as a consequence of their use.CrossRef

14.

Glade MJ. Caffeine-not just a stimulant. Nutrition. 2010;26:932–8.PubMedCrossRef

15.

Budney AJ, Brown PC, Griffiths RR, Hughes JR, Juliano LM. Caffeine withdrawal and dependence: a convenience survey among addiction professionals. J Caffeine Res. 2013;3:67–71.PubMedCentralPubMedCrossRef

16.••

Meredith SE, Juliano LM, Hughes JR, Griffiths RR. Caffeine use disorder: a comprehensive review and research agenda. J Caffeine Res. 2013;3:114–30. Meredith et al. present a thorough review of the evidence in support of caffeine dependence and describe an agenda for future research on clinical, epidemiological, and genetic investigations of caffeine dependence and CUD. Of note, evidence is described in support of the three primary criteria for CUD, and three case reports of individuals seeking treatment for caffeine dependence are presented. The authors recommend more research on the prevalence of CUD in the general population and the severity of functional impairment associated with the disorder, as well as efficacious treatment options for affected individuals.PubMedCrossRef

17.

Lara DR. Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis. 2010;20:S239–48.PubMed

18.•

McCarthy DM, Mycyk MB, DesLauriers CA. Hospitalization for caffeine abuse is associated with abuse of other pharmaceutical products. Am J Emerg Med. 2008;26:799–802. McCarthy et al. performed a retrospective review of all caffeine-related reports to the Illinois Poison Center between 2002 and 2004. Instances of caffeine abuse were included for analysis. The authors reported that caffeine was most often abused in the form of a non-dietary medication, followed by caffeine-enhanced beverages, then dietary supplements. Forty-two percent of cases were managed in an emergency department and 13 % of patients were hospitalized. The need for hospitalization was associated with concomitant abuse of other pharmaceuticals.PubMedCrossRef

19.•

Ogawa N, Ueki H. Clinical importance of caffeine dependence and abuse. Psychiatry Clin Neurosci. 2007;61:263–8. The authors present two case reports of individuals whose caffeine use escalated to a point when they needed medical intervention for symptoms of caffeine intoxication. These case reports illustrate how caffeine use can become a clinically relevant disorder in some individuals. The authors also review evidence that caffeine abuse/dependence can manifest itself similar to other drugs of abuse. The authors recommend improved labeling of caffeinated products for consumer awareness.PubMedCrossRef

20.

Nawrot P, Jordan S, Eastwood J, et al. Effects of caffeine on human health. Food Addit Contam. 2003;20:1–30.PubMedCrossRef

21.

Palatini P, Dorigatti F, Santonastaso M, et al. Association between coffee consumption and risk of hypertension. Ann Med. 2007;39:545–53.PubMedCrossRef

22.

Klag MJ, Wang NY, Meoni LA, et al. Coffee intake and risk of hypertension - The Johns Hopkins precursors study. Arch Intern Med. 2002;162:657–62.PubMedCrossRef

23.

Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113–26.PubMedCrossRef

24.

Zhang ZZ, Hu G, Caballero B, Appel L, Chen LW. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. Am J Clin Nutr. 2011;93:1212–9.PubMedCrossRef

25.

Griffiths RR, Evans SM, Heishman SJ, et al. Low-dose caffeine physical-dependence in humans. J Pharmacol Exp Ther. 1990;255:1123–32.PubMed

26.

Winston AP, Hardwick E, Jaberi N. Neuropsychiatric effects of caffeine. Adv Psychiatr Treat. 2005;11:432–9.CrossRef

27.

Vilarim MM, Araujo DMR, Nardi AE. Caffeine challenge test and panic disorder: a systematic literature review. Expert Rev Neurother. 2011;11:1185–95.PubMedCrossRef

28.

Ciapparelli A, Paggini R, Carmassi C, et al. Patterns of caffeine consumption in psychiatric patients. An Italian study. Eur Psychiatry. 2010;25:230–5.PubMedCrossRef

29.

Kendler KS, Myers J, Gardner CO. Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med. 2006;36:1717–25.PubMedCrossRef

30.

Ferreira SE, de Mello MT, Pompeia S, de Souza-Formigoni MLO. Effects of energy drink ingestion on alcohol intoxication. Alcohol Clin Exp Res. 2006;30:598–605.PubMedCrossRef

31.••

Temple JL. Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev. 2009;33:793–806. Review of caffeine literature, including sources of caffeine and consumption patterns; physiological mechanisms; evidence for addiction, tolerance, and sensitization; and caffeine conditioning and reinforcement value. A special emphasis is given to caffeine use among children and adolescents. In particular, cross-sensitization between caffeine and sugary beverages could set up poor dietary habits across the lifespan. Also, children and adolescents may experience pressure in the classroom and from coaches to drink caffeine for its putative performance-enhancing effects. The author concludes that research is lacking on caffeine use in children and adolescents, but the long-term effects of caffeine exposure during a critical period of development may be a cause for concern.PubMedCentralPubMedCrossRef

32.

Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. 2001;357:505–8.PubMedCrossRef

33.

Majewski RF. Dental caries in adolescents associated with caffeinated carbonated beverages. Pediatr Dent. 2001;23:198–203.PubMed

34.

Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks–a growing problem. Drug Alcohol Depend. 2009;99:1–10.PubMedCentralPubMedCrossRef

35.

Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc. 2005;105:110–3.PubMedCrossRef

Titel: Caffeine Use Disorder: A Review of the Evidence and Future Implications
verfasst von: Merideth A. Addicott
Publikationsdatum: 01.09.2014
Verlag: Springer International Publishing
Erschienen in: Current Addiction Reports / Ausgabe 3/2014
Elektronische ISSN: 2196-2952
DOI: https://doi.org/10.1007/s40429-014-0024-9

Neu im Fachgebiet Psychiatrie

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Caffeine Use Disorder: A Review of the Evidence and Future Implications

Abstract

Neu im Fachgebiet Psychiatrie

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Demenzkranke durch Antipsychotika vielfach gefährdet

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

Update Psychiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Clinical and Research Implications of Gambling Disorder in DSM-5

DSM-5 and the Decision Not to Include Sex, Shopping or Stealing as Addictions

The Elimination of Abuse and Dependence in DSM-5 Substance Use Disorders: What Does This Mean for Treatment?

Internet Gaming Disorder

Five years of the Yale Food Addiction Scale: Taking stock and moving forward

HIV Medications as Drugs of Abuse

Neu im Fachgebiet Psychiatrie

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Demenzkranke durch Antipsychotika vielfach gefährdet

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

Update Psychiatrie